Search Results - "DURAND, M. C"

Refine Results
  1. 1

    SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism by Durand, C M, Perroy, J, Loll, F, Perrais, D, Fagni, L, Bourgeron, T, Montcouquiol, M, Sans, N

    Published in Molecular psychiatry (01-01-2012)
    “…Genetic mutations of SHANK3 have been reported in patients with intellectual disability, autism spectrum disorder (ASD) and schizophrenia. At the synapse,…”
    Get full text
    Journal Article
  2. 2

    Abnormal melatonin synthesis in autism spectrum disorders by Melke, J, Goubran Botros, H, Chaste, P, Betancur, C, Nygren, G, Anckarsäter, H, Rastam, M, Ståhlberg, O, Gillberg, I C, Delorme, R, Chabane, N, Mouren-Simeoni, M-C, Fauchereau, F, Durand, C M, Chevalier, F, Drouot, X, Collet, C, Launay, J-M, Leboyer, M, Gillberg, C, Bourgeron, T

    Published in Molecular psychiatry (01-01-2008)
    “…Melatonin is produced in the dark by the pineal gland and is a key regulator of circadian and seasonal rhythms. A low melatonin level has been reported in…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Overcoming barriers and stigma: new frontiers in solid organ transplantation for people with HIV by Storm, K, Durand, C M

    Published in Clinical microbiology reviews (14-03-2024)
    “…There is a growing need for solid organ transplantation (SOT) for people living with human immunodeficiency virus (HIV). With the advent of antiretroviral…”
    Get more information
    Journal Article
  5. 5

    Increased incidence of Campylobacter jejuni-associated Guillain–Barré syndromes in the Greater Paris area by SIVADON-TARDY, V., PORCHER, R., ORLIKOWSKI, D., RONCO, E., GAULT, E., ROUSSI, J., DURAND, M.-C., SHARSHAR, T., ANNANE, D., RAPHAEL, J.-C., MEGRAUD, F., GAILLARD, J.-L.

    Published in Epidemiology and infection (01-08-2014)
    “…The role of Campylobacter jejuni as the triggering agent of Guillain–Barré syndrome (GBS) has not been reassessed since the end of the 1990s in France. We…”
    Get full text
    Journal Article
  6. 6

    False-positive hepatitis C virus serology after placement of a ventricular assistance device by Durand, C.M., Marr, K.A., Ostrander, D., Subramanian, A., Valsamakis, A., Cox, A., Neofytos, D.

    Published in Transplant infectious disease (01-02-2016)
    “…Background Ventricular assist devices (VADs) have been associated with immune activation and sensitization. We observed several cases of false‐positive (FP)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Significance of phrenic nerve electrophysiological abnormalities in Guillain-Barré syndrome by DURAND, M.-C, PRIGENT, H, SHARSHAR, T, SIVADON-TARDY, V, ORLIKOWSKI, D, CAUDIE, C, DEVAUX, C, CLAIR, B, GAILLARD, J.-L, LOFASO, F, RAPHAEL, J.-C

    Published in Neurology (22-11-2005)
    “…The authors investigated whether the amplitude and latency of diaphragm compound muscle action potential helped predict respiratory failure in Guillain-Barré…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Electrophysiology to predict mechanical ventilation in Guillain-Barré syndrome by Durand, M.-C., Lofaso, F., Lefaucheur, J.-P., Chevret, S., Gajdos, Ph, Raphaël, J.-C., Sharshar, T.

    Published in European journal of neurology (01-01-2003)
    “…To determine whether electrophysiological features predict endotracheal mechanical ventilation (ETMV) in Guillain–Barré syndrome (GBS). Non‐ventilated GBS…”
    Get full text
    Journal Article
  11. 11

    Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent Era by Bowring, M. G., Kucirka, L. M., Massie, A. B., Luo, X., Cameron, A., Sulkowski, M., Rakestraw, K., Gurakar, A., Kuo, I., Segev, D. L., Durand, C. M.

    Published in American journal of transplantation (01-02-2017)
    “…The impact of interferon (IFN)‐free direct‐acting antiviral (DAA) hepatitis C virus (HCV) treatments on utilization and outcomes associated with HCV‐positive…”
    Get full text
    Journal Article
  12. 12

    Challenges and Clinical Decision‐Making in HIV‐to‐HIV Transplantation: Insights From the HIV Literature by Boyarsky, B. J., Durand, C. M., Palella, F. J., Segev, D. L.

    Published in American journal of transplantation (01-08-2015)
    “…Life expectancy among HIV‐infected (HIV+) individuals has improved dramatically with effective antiretroviral therapy. Consequently, chronic diseases such as…”
    Get full text
    Journal Article
  13. 13

    Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus by Kucirka, L. M., Durand, C. M., Bae, S., Avery, R. K., Locke, J. E., Orandi, B. J., McAdams‐DeMarco, M., Grams, M. E., Segev, D. L.

    Published in American journal of transplantation (01-08-2016)
    “…There is an increased risk of acute rejection (AR) in human immunodeficiency virus–positive (HIV+) kidney transplant (KT) recipients. Induction…”
    Get full text
    Journal Article
  14. 14

    The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes by Axelrod, D. A., Schnitzler, M. A., Alhamad, T., Gordon, F., Bloom, R. D., Hess, G. P., Xiao, H., Nazzal, M., Segev, D. L., Dharnidharka, V. R., Naik, A. S., Lam, N. N., Ouseph, R., Kasiske, B. L., Durand, C. M., Lentine, K. L.

    Published in American journal of transplantation (01-10-2018)
    “…Direct‐acting antiviral medications (DAAs) have revolutionized care for hepatitis C positive (HCV+) liver (LT) and kidney (KT) transplant recipients…”
    Get full text
    Journal Article
  15. 15

    Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience by Neofytos, D., Treadway, S., Ostrander, D., Alonso, C.D., Dierberg, K.L., Nussenblatt, V., Durand, C.M., Thompson, C.B., Marr, K.A.

    Published in Transplant infectious disease (01-06-2013)
    “…Background The epidemiology of invasive mold infections (IMI) in transplant recipients differs based on geography, hosts, preventative strategies, and methods…”
    Get full text
    Journal Article
  16. 16

    A gene for an autosomal recessive lower motor neuron disease with childhood onset maps to 1p36 by Maystadt, I, Zarhrate, M, Leclair-Richard, D, Estournet, B, Barois, A, Renault, F, Routon, M-C, Durand, M-C, Lefebvre, S, Munnich, A, Verellen-Dumoulin, C, Viollet, L

    Published in Neurology (11-07-2006)
    “…To describe the clinical features of a novel variant of autosomal recessive lower motor neuron disease (LMND) with childhood onset and to map the…”
    Get full text
    Journal Article
  17. 17

    HIV Cure: Knocking on the Door by Durand, C M, Flexner, C

    Published in Clinical pharmacology and therapeutics (01-05-2013)
    “…Although major advances in drug development and public health are helping to control the HIV/AIDS epidemic, there is a strong rationale for pursuing a more…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Hydrogenase Activity Control at Desulfovibrio vulgaris Cell-Coated Carbon Electrodes: Biochemical and Chemical Factors Influencing the Mediated Bioelectrocatalysis by Lojou, E., Durand, M. C., Dolla, A., Bianco, P.

    Published in Electroanalysis (New York, N.Y.) (01-07-2002)
    “…Hydrogen uptake and evolution reactions have been electrochemically measured using a glassy carbon electrode modified by a coating made of whole Desulfovibrio…”
    Get full text
    Journal Article
  20. 20